News
NewsLetter July
Operator Experience and Radiation Exposure During Transradial and Transfemoral Procedures
FFR Identifies ACS Patients Who Do Not Need Revascularization
Aortic Regurgitation After Cardiac Catheterization
Magnetic Resonance Imaging and Troponin Elevation Following Percutaneous Coronary Intervention: New Insights Into Myocyte Necrosis and Scar Formation
Intracoronary Thrombus: A Sticky Problem
Fast Hypothermia Before PCI Limits Infarct Size in STEMI Patients
Early PCI After Fibrinolysis Safely Reduces Reinfarction, Recurrent Ischemia
About IHT
Introduction
History
Quality
R & D
In the World
Divisions
IHT Cordynamic
IHT Hospital Care
IHT Biopur
Where we are
Products
Hospital Products
Catheters protector
Drains
Dressings
Humidifyers
Plasters
Surgery paths
Surgical Aspiration
Surgical Protection
Interventional cardiology
AMI Catherers
Balloon Catheters
Bare Metal Stents
Drug Eluting Stents
Guiding Catheters
Inert Stents
Biomedic Solutions
Biopur solutions
Technology
News
Careers
Private Area
Contact us
|
Español
New Products
R&D&i, production and logistics
Caring about patients
Delivering solutions
IHT Cordynamic
Interventional cardiology
IHT Hospital Care
Hospital Products
IHT Biopur
Biomedic Solutions
IHT in the world
The quality of our products and our strategic / marketing efforts have led to Iberhospitex being present in both domestic and international markets.
We are determined to expand into all continents.
Europe
North America
Latinamerica
Africa
Asia and Middle East
